| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 2001 | 2018 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1989 | 2015 | ||||||||
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2005 | 2017 | |||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 2010 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 2004 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 1998 | 2018 | |||||||||
|
ISL LIM homeobox 1 | 0.579 | 0.654 | 0.87 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 1993 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.340 | None | 1.000 | 5 | 1 | 2005 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.330 | None | 0.750 | 4 | 1 | 2005 | 2018 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
disease | 0.330 | None | 0.667 | 3 | 0 | 1990 | 2017 | ||||||||
|
T-box transcription factor 2 | 0.544 | 0.769 | 0.99 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2003 | 2010 | ||||||||
|
neuronatin | 0.633 | 0.538 | 0.40 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
Ras association domain family member 5 | 0.641 | 0.577 | 4.3E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2008 | 2012 | ||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 14 | 0.638 | 0.615 | 0.22 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2015 | 2020 | ||||||||
|
semaphorin 3B | 0.633 | 0.615 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
dedicator of cytokinesis 8 | 0.578 | 0.731 | 1.5E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
chromodomain helicase DNA binding protein 6 | 0.780 | 0.346 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
heart and neural crest derivatives expressed 2 | 0.612 | 0.500 | 0.40 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.200 | None | 0.953 | 43 | 0 | 2002 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 38 | 0 | 1990 | 2019 |